ACURA PHARMACEUTICALS, INC
ACURA PHARMACEUTICALS, INC (ACUR) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 403 transactions totaling $23.3M, demonstrating a bearish sentiment with -$22.4M in net insider flow. The most recent transaction on Jan 2, 2026 involved a transaction of 50,000 shares valued at $0.
ACUR Insider Activity Summary
Who Is Buying ACUR Stock?
No significant insider buying has been recorded for ACUR in the recent period.
Who Is Selling ACUR Stock?
No significant insider selling has been recorded for ACUR in the recent period.
Is ACURA PHARMACEUTICALS, INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ACUR is bearish with an Insider Alignment Score of 2/100 and a net flow of -$22.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ACUR Frequently Asked Questions
Understanding ACUR Insider Activity
Insider trading at ACURA PHARMACEUTICALS, INC (ACUR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading ACUR stock, having executed 403 transactions in the past 90 days. The most active insider is John Schutte (Executive), who has made 1 transactions totaling $6.9M.
Related Tools
Track ACURA PHARMACEUTICALS, INC Insider Activity
Get notified when executives and directors at ACUR file new Form 4 transactions